Viewing Study NCT05742269

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2026-01-29 @ 11:58 PM
Study NCT ID: NCT05742269
Status: RECRUITING
Last Update Posted: 2025-02-26
First Post: 2023-01-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Molecular PD-L1 PET/CT Imaging With 89Zr-atezolizumab in Metastatic Triple Negative Breast Cancer
Sponsor: Karolinska University Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Triple-Negative Breast Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None 89Zr-atezolizumab View
None PD-L1 PET View
None predictive biomarker View